{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:19:27Z","timestamp":1773116367261,"version":"3.50.1"},"reference-count":37,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.3892\/ol.2016.4880","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T09:50:50Z","timestamp":1468835450000},"page":"1826-1832","source":"Crossref","is-referenced-by-count":47,"title":["Valproic acid induces autophagy by suppressing the Akt\/mTOR pathway in human prostate cancer cells"],"prefix":"10.3892","volume":"12","author":[{"given":"Qinghua","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunbo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"key":"key20180108110313_b1-ol-0-0-4880","doi-asserted-by":"crossref","DOI":"10.1038\/pcan.2016.17","article-title":"Androgen receptor variant-driven prostate cancer: Clinical implications and therapeutic targeting","author":"Antonarakis","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key20180108110313_b2-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20180108110313_b3-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11255-013-0609-6","article-title":"Role of SMAD4 in the mechanism of valproic acid's inhibitory effect on prostate cancer cell invasiveness","volume":"46","author":"Jiang","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"key20180108110313_b4-ol-0-0-4880","doi-asserted-by":"crossref","DOI":"10.1007\/s11523-016-0441-x","article-title":"Combinatorial study of a novel poly (ADP-ribose) polymerase inhibitor and an HDAC inhibitor, SAHA, in leukemic cell lines","author":"Hegde","year":"2016","journal-title":"Target Oncol"},{"key":"key20180108110313_b5-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.molonc.2012.07.003","article-title":"Histone deacetylases and cancer","volume":"6","author":"Barneda-Zahonero","year":"2012","journal-title":"Mol Oncol"},{"key":"key20180108110313_b6-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4155\/fmc.12.80","article-title":"Histone deacetylase inhibitors in the treatment of cancer: Overview and perspectives","volume":"4","author":"Giannini","year":"2012","journal-title":"Future Med Chem"},{"key":"key20180108110313_b7-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"479364","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"key20180108110313_b8-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","article-title":"Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo","volume":"66","author":"Xia","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108110313_b9-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1442-2042.2007.01823.x","article-title":"Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo","volume":"14","author":"Gao","year":"2007","journal-title":"Int J Urol"},{"key":"key20180108110313_b10-ol-0-0-4880","first-page":"44","article-title":"Effect of valproic acid on autophagy in prostate cancer PC3 cells","volume":"49","author":"Huang","year":"2011","journal-title":"Shandong Da Xue Xue Bao"},{"key":"key20180108110313_b11-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"e94616","DOI":"10.1371\/journal.pone.0094616","article-title":"IPF fibroblasts are desensitized to type I collagen matrix-induced cell death by suppressing low autophagy via aberrant Akt\/mTOR kinases","volume":"9","author":"Nho","year":"2014","journal-title":"PLoS One"},{"key":"key20180108110313_b12-ol-0-0-4880","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-016-1577-6","article-title":"Intraneuronal aggregation of the \u03b2-CTF fragment of APP (C99) induces A\u03b2-independent lysosomal-autophagic pathology","author":"Lauritzen","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key20180108110313_b13-ol-0-0-4880","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2016.1170257","article-title":"Defective recognition of LC3B by mutant SQSTM1\/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD","author":"Goode","year":"2016","journal-title":"Autophagy"},{"key":"key20180108110313_b14-ol-0-0-4880","article-title":"Cell death and neurodegeneration in the postnatal development of cerebellar vermis in normal and Reeler mice","author":"Castagna","year":"2016","journal-title":"Ann Anat"},{"key":"key20180108110313_b15-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13277-010-0126-5","article-title":"The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells","volume":"32","author":"Zhao","year":"2011","journal-title":"Tumour Biol"},{"key":"key20180108110313_b16-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2016.00114","article-title":"Intrinsic and tumor microenvironment-induced metabolism adaptations of T cells and impact on their differentiation and function","volume":"7","author":"Kouidhi","year":"2016","journal-title":"Front Immunol"},{"key":"key20180108110313_b17-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cpr.12095","article-title":"Unravelling the multifaceted roles of Atg proteins to improve cancer therapy","volume":"47","author":"Chen","year":"2014","journal-title":"Cell Prolif"},{"key":"key20180108110313_b18-ol-0-0-4880","first-page":"3129","article-title":"Histone deacetylase (HDAC) inhibitors: Current evidence for therapeutic activities in pancreatic cancer","volume":"35","author":"Damaskos","year":"2015","journal-title":"Anticancer Res"},{"key":"key20180108110313_b19-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543776.2013.736493","article-title":"Histone deacetylase inhibitors: A patent review (2009-2011)","volume":"23","author":"Carafa","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"key20180108110313_b20-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1590\/S1415-475738420150028","article-title":"Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1","volume":"38","author":"Lee","year":"2015","journal-title":"Genet Mol Biol"},{"key":"key20180108110313_b21-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3892\/or.2013.2959","article-title":"Antitumour effect of valproic acid against salivary gland cancer in vitro and in vivo","volume":"31","author":"Nagai","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180108110313_b22-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biotechadv.2014.03.006","article-title":"From nature to bedside: Pro-survival and cell death mechanisms as therapeutic targets in cancer treatment","volume":"32","author":"Cerella","year":"2014","journal-title":"Biotechnol Adv"},{"key":"key20180108110313_b23-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1440-1789.2010.01197.x","article-title":"Induction of autophagy in temozolomide treated malignant gliomas","volume":"31","author":"Natsumeda","year":"2011","journal-title":"Neuropathology"},{"key":"key20180108110313_b24-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/1541-7786.MCR-10-0471","article-title":"Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis","volume":"9","author":"Chen","year":"2011","journal-title":"Mol Cancer Res"},{"key":"key20180108110313_b25-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3410\/B3-25","article-title":"The puzzling origin of the autophagosomal membrane","volume":"3","author":"Mari","year":"2011","journal-title":"F1000 Biol Rep"},{"key":"key20180108110313_b26-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cdd.2008.139","article-title":"Autophagy in aging, disease and death: The true identity of a cell death impostor","volume":"16","author":"Levine","year":"2009","journal-title":"Cell Death Differ"},{"key":"key20180108110313_b27-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"e84392","DOI":"10.1371\/journal.pone.0084392","article-title":"HRES-1\/Rab4 promotes the formation of LC3(+) autophagosomes and the accumulation of mitochondria during autophagy","volume":"9","author":"Talaber","year":"2014","journal-title":"PLoS One"},{"key":"key20180108110313_b28-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/cells1030396","article-title":"LC3-associated phagocytosis (LAP): Connections with host autophagy","volume":"1","author":"Lai","year":"2012","journal-title":"Cells"},{"key":"key20180108110313_b29-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"pdb.prot086512","DOI":"10.1101\/pdb.prot086512","article-title":"Detection of autophagy in Caenorhabditis elegans by western blotting analysis of LGG-1","volume":"2016","author":"Palmisano","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"key":"key20180108110313_b30-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"key20180108110313_b31-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/crj.12148","article-title":"Expression of beclin 1 in non-small cell lung cancer: An immunohistochemical study","volume":"9","author":"Lv","year":"2015","journal-title":"Clin Respir J"},{"key":"key20180108110313_b32-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ncb1426","article-title":"Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG","volume":"8","author":"Liang","year":"2006","journal-title":"Nat Cell Biol"},{"key":"key20180108110313_b33-ol-0-0-4880","article-title":"The signaling involving in autophagy machinery in keratinocytes and therapeutic approaches for skin diseases","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"key20180108110313_b34-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"e0152628","DOI":"10.1371\/journal.pone.0152628","article-title":"mTOR hyperactivation by ablation of tuberous sclerosis complex 2 in the mouse heart induces cardiac dysfunction with the increased number of small mitochondria mediated through the down-regulation of autophagy","volume":"11","author":"Taneike","year":"2016","journal-title":"PLoS One"},{"key":"key20180108110313_b35-ol-0-0-4880","doi-asserted-by":"crossref","DOI":"10.1007\/s12253-016-0066-5","article-title":"The gene expression status of the PI3K\/AKT\/mTOR pathway in Gastric Cancer Tissues and cell lines","author":"Riquelme","year":"2016","journal-title":"Pathol Oncol Res"},{"key":"key20180108110313_b36-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/15548627.2016.1157237","article-title":"Phosphorylation of Atg9 regulates movement to the phagophore assembly site and the rate of autophagosome formation","volume":"12","author":"Feng","year":"2016","journal-title":"Autophagy"},{"key":"key20180108110313_b37-ol-0-0-4880","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.phrs.2011.11.008","article-title":"The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice","volume":"65","author":"Malfitano","year":"2012","journal-title":"Pharmacol Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4880\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T14:48:46Z","timestamp":1515422926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,7,18]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.3892\/ol.2016.4880"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4880","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]}}}